| Year |
Citation |
Score |
| 2016 |
Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z, Du L, Zheng L, Ke C, Huang X, Song H, Kumar R, Yeung SC, Zhang H. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Oncogene. PMID 27345410 DOI: 10.1038/onc.2016.213 |
0.611 |
|
| 2016 |
Yao S, To KK, Ma L, Yin C, Tang C, Chai S, Ke CQ, Lin G, Ye Y. Polyoxypregnane steroids with an open-chain sugar moiety from Marsdenia tenacissima and their chemoresistance reversal activity. Phytochemistry. PMID 26988729 DOI: 10.1016/j.phytochem.2016.03.006 |
0.493 |
|
| 2014 |
Lu ZM, Luo TH, Nie MM, Fang GE, Ma LY, Xue XC, Wei G, Ke CW, Bi JW. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 2941-8. PMID 24318989 DOI: 10.1007/s13277-013-1378-7 |
0.542 |
|
| 2013 |
Huang YT, Li FF, Ke C, Li Z, Li ZT, Zou XF, Zheng XX, Chen YP, Zhang H. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy. Journal of Translational Medicine. 11: 245. PMID 24090193 DOI: 10.1186/1479-5876-11-245 |
0.513 |
|
| 2013 |
Lu Z, Luo T, Nie M, Bi J, Ke C, Xue X, Ma L, Fang G. Genetic polymorphisms of XRCC1 gene and susceptibility to gastric cancer in Chinese Han population. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 18: 542-6. PMID 23919819 DOI: 10.3109/1354750X.2013.822562 |
0.563 |
|
| 2012 |
Ke B, Ran L, Wu S, Deng X, Ke C, Feng Z, Ma L, Varma JK. Survey of physician diagnostic and treatment practices for patients with acute diarrhea in Guangdong province, China. Foodborne Pathogens and Disease. 9: 47-53. PMID 21988400 DOI: 10.1089/fpd.2011.0964 |
0.491 |
|
| Show low-probability matches. |